G

Genincode PLC
LSE:GENI

Watchlist Manager
Genincode PLC
LSE:GENI
Watchlist
Price: 1.8 GBX Market Closed
Market Cap: 5.2m GBX

Net Margin
Genincode PLC

-164.2%
Current
-330%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-164.2%
=
Net Income
-4.4m
/
Revenue
2.7m

Net Margin Across Competitors

Genincode PLC
Glance View

Market Cap
5.2m GBX
Industry
Health Care

GENinCode UK Ltd. engages in the risk assessment and prediction of cardiovascular disease. The company is headquartered in Oxford, Oxfordshire. The company went IPO on 2021-07-22. The firm develops patented deoxyribonucleic acid (DNA) risk assessment products which utilize artificial intelligence (AI), bioinformatics and a globally recognized clinical evidence base to provide predictive analysis of a patient’s health risk. The Company’s clinical diagnostic tests cover global disease areas such as cardiovascular, cancer and diabetes.

GENI Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-164.2%
=
Net Income
-4.4m
/
Revenue
2.7m
What is the Net Margin of Genincode PLC?

Based on Genincode PLC's most recent financial statements, the company has Net Margin of -164.2%.

Back to Top